Engineering an Insulin Complex to Treat Diabetes
New England Journal of Medicine · 2024
DOI: 10.1056/nejmcibr2400047 ↗Kurz gefasst
Fachartikel in der Zeitschrift New England Journal of Medicine, 2024. Verfasst von William T Cefalu und 1 weiteren Autor:innen. Beteiligte Einrichtung: From the Division of Diabetes, Endocrinology, and Metabolic Diseases, National Institute of Diabetes and Digestive and Kidney Diseases, National Inst…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Hypoglycemic Agents, Insulin, Drug Design. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 5 Literaturangaben.
Themen: Diabetes mellitus
Abstract (Originalsprache)
A subcutaneously injected glucose-responsive insulin was tested for efficacy on blood glucose levels in animal models of type 1 diabetes but may also help persons with type 2 diabetes receiving insulin therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- From the Division of Diabetes, Endocrinology, and Metabolic Diseases, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD.
Zitieren
APA
Cefalu, W. T., & Arreaza-Rubín, G. (2024). Engineering an Insulin Complex to Treat Diabetes. New England Journal of Medicine. https://doi.org/10.1056/nejmcibr2400047
Vancouver
Cefalu WT, Arreaza-Rubín G. Engineering an Insulin Complex to Treat Diabetes. New England Journal of Medicine. 2024. doi:10.1056/nejmcibr2400047
BibTeX
@article{Cefalu2024,
author = {Cefalu, William T and Arreaza-Rubín, Guillermo},
title = {Engineering an Insulin Complex to Treat Diabetes},
journal = {New England Journal of Medicine},
year = {2024},
doi = {10.1056/nejmcibr2400047}
}
EUVIMED